Royal Bank of Canada Sells 9,805 Shares of Integer Holdings Co. (NYSE:ITGR)

Royal Bank of Canada lessened its stake in Integer Holdings Co. (NYSE:ITGR - Free Report) by 2.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 471,865 shares of the medical equipment provider's stock after selling 9,805 shares during the quarter. Royal Bank of Canada owned 1.41% of Integer worth $62,533,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in the business. Mather Group LLC. increased its holdings in shares of Integer by 304.3% in the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 143 shares during the period. Lee Danner & Bass Inc. acquired a new position in Integer during the fourth quarter worth $27,000. R Squared Ltd acquired a new position in Integer during the fourth quarter worth $44,000. Sterling Capital Management LLC grew its holdings in Integer by 472.9% during the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock worth $45,000 after acquiring an additional 279 shares during the period. Finally, Principal Securities Inc. grew its holdings in Integer by 31.2% in the fourth quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider's stock valued at $85,000 after purchasing an additional 152 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

Integer Price Performance

Shares of Integer stock traded up $0.27 during trading on Friday, hitting $118.43. The stock had a trading volume of 244,616 shares, compared to its average volume of 372,128. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The firm has a market cap of $4.13 billion, a P/E ratio of 35.25, a PEG ratio of 1.72 and a beta of 1.03. The business has a fifty day moving average of $118.40 and a two-hundred day moving average of $129.22. Integer Holdings Co. has a fifty-two week low of $104.93 and a fifty-two week high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last announced its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The company had revenue of $437.39 million for the quarter, compared to analyst estimates of $428.51 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. Integer's revenue for the quarter was up 7.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.14 earnings per share. On average, sell-side analysts expect that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of the company's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the transaction, the chief executive officer now directly owns 47,000 shares of the company's stock, valued at $5,788,990. This represents a 87.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 2.16% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Benchmark lowered their target price on Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a report on Friday, April 25th. Oppenheimer downgraded Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Truist Financial set a $150.00 target price on Integer and gave the stock a "buy" rating in a research report on Friday, April 25th. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and raised their price objective for the stock from $133.00 to $140.00 in a report on Thursday. Finally, Wall Street Zen upgraded Integer from a "sell" rating to a "hold" rating in a report on Monday, May 19th. Two investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $145.00.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.